IDH1 and IDH2 mutation status of lymphoma samples
| Disease . | IDH1R132 . | IDH2R172 . | IDH2R140 . |
|---|---|---|---|
| Tenomic Consortium and University of Hong Kong patients | |||
| Hodgkin lymphoma | 0/66 | 0/66 | 0/66 |
| Non-Hodgkin B-cell lymphoma | 0/14 | 0/14 | 0/14 |
| B-cell acute lymphoblastic lymphoma (ALL B) | 0/32 | 0/32 | 0/32 |
| T-cell acute lymphoblastic lymphoma (ALL T) | 0/8 | 0/8 | 0/8 |
| AML | 2/8 | 0/8 | 0/8 |
| PTCL | |||
| PTCL not otherwise specified (PTCLnos) | 0/43 | 0/43 | 0/43 |
| Anaplastic large cell lymphoma (ALCL) | 0/50 | 0/50 | 0/50 |
| Enteropathy type T-cell lymphoma (ETL) | 0/8 | 0/8 | 0/8 |
| Cutaneous T-cell lymphoma (CTCL) | 0/17 | 0/17 | 0/17 |
| Hepatosplenic T-cell lymphoma (HSTCL) | 0/10 | 0/10 | 0/10 |
| Extranodal NK/T-cell lymphoma (NK/TCL) | 0/10 | 0/10 | 0/10 |
| AITL | 0/79 | 15/79 | 1/79 |
| UNMC patients | |||
| AITL | 0/22 | 10/22 | 0/22 |
| Disease . | IDH1R132 . | IDH2R172 . | IDH2R140 . |
|---|---|---|---|
| Tenomic Consortium and University of Hong Kong patients | |||
| Hodgkin lymphoma | 0/66 | 0/66 | 0/66 |
| Non-Hodgkin B-cell lymphoma | 0/14 | 0/14 | 0/14 |
| B-cell acute lymphoblastic lymphoma (ALL B) | 0/32 | 0/32 | 0/32 |
| T-cell acute lymphoblastic lymphoma (ALL T) | 0/8 | 0/8 | 0/8 |
| AML | 2/8 | 0/8 | 0/8 |
| PTCL | |||
| PTCL not otherwise specified (PTCLnos) | 0/43 | 0/43 | 0/43 |
| Anaplastic large cell lymphoma (ALCL) | 0/50 | 0/50 | 0/50 |
| Enteropathy type T-cell lymphoma (ETL) | 0/8 | 0/8 | 0/8 |
| Cutaneous T-cell lymphoma (CTCL) | 0/17 | 0/17 | 0/17 |
| Hepatosplenic T-cell lymphoma (HSTCL) | 0/10 | 0/10 | 0/10 |
| Extranodal NK/T-cell lymphoma (NK/TCL) | 0/10 | 0/10 | 0/10 |
| AITL | 0/79 | 15/79 | 1/79 |
| UNMC patients | |||
| AITL | 0/22 | 10/22 | 0/22 |